Oxford Vaccine up to 90% effective. Will be sold at cost to developing nations in perpetuity
The University of Oxford and AstraZeneca have announced that the vaccine ChAdOx1 nCoV-2019 is up to 90% effective at preventing Covid-19. AstraZeneca have also promised that the Vaccine will be sold at cost – between $3-$4 a dose – to all nations during the pandemic, and to developing nations in perpetuity. This is a fraction […]
Continue Reading